We are pleased to present the February issue of Dechert LLP’s UK Life Sciences and Healthcare Newsletter.
This month's Newsletter provides an insight into current developments, analysis and news, including:
- An update in relation to a recent draft EU Regulation that aims to encourage the sharing and re-use of data
- An update on the latest development in the warranty and indemnity (W&I) insurance market: synthetic warranty coverage, and its possible application in the transaction process.
- A Committed Capital podcast episode discussing various opportunities affecting private equity investment in life sciences and healthcare and how the U.S. and European markets are shaping up in 2021 and beyond
- A guest contributor feature from David Miles, CEO of AKL Research and Development: "Are We Nearly There Yet? The Search for a Disease Modifying Drug for Osteoarthritis"
Related Professionals
